This is a firm-fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), to Quanterix Corporation. The contract, valued at $135,937.50, is for the provision of the Quanterix ELISA (Enzyme-Linked Immunosorbent Assay) System, which is used for ultra-sensitive digital biomarker detection. This contract was set aside for small businesses. Quanterix Corporation is a life sciences company specializing in advanced...
This is a $19,170.11 firm-fixed-price purchase order contract awarded by the National Institute of Nursing Research, a civilian agency, to Quanterix Corporation, a life sciences company specializing in ultra-sensitive digital biomarker detection technology. The contract is for the provision of Quanterix's Simoa (single molecule array) instruments, assay kits, and research services, which enable the measurement of proteins and other biomarkers at unprecedented levels of sensitivity. This supports...
This firm-fixed-price purchase order was awarded by the National Institute of Nursing Research (NINR), a civilian agency under the National Institutes of Health (NIH), to Quanterix Corporation, a life sciences company specializing in ultra-sensitive digital biomarker detection technology. The $3,070.94 contract is for the procurement of Quanterix's Simoa (single molecule array) biomarker detection equipment and related maintenance services. Quanterix has received multiple federal contract awards...
This is a firm fixed-price purchase order awarded by the Department of Health and Human Services National Institutes of Health Office of Logistics and Acquisition Operations to Quanterix Corporation, a life sciences company that provides ultra-sensitive digital biomarker detection technology. The contract, valued at $100,500.00, is for custom assay development services. Quanterix has received over $30 million in prior federal contracts from agencies including the National Institutes of Health,...
The Department of Health and Human Services, National Institutes of Health awarded a firm fixed price purchase order to Quanterix Corporation, a for-profit manufacturer of goods, for the N4PA SIMOA 2.0 ASSAY KIT. The $112,969.08 award, with an October 2020 completion date, was not set aside. Quanterix has received over $30 million in prior federal contracts from agencies like the NIH, Department of Veterans Affairs, and Department of Defense to supply its ultra-sensitive digital biomarker...
This is a $119,614.50 firm-fixed-price purchase order awarded by the Department of Health and Human Services National Institutes of Health National Institute on Aging to Quanterix Corporation, a life sciences company that provides ultra-sensitive digital biomarker detection technology. The award is for Quanterix's Simoa 4-plex and Singleplex 96-well Plate Assays, including reagents, buffers, and shipping, to support the NIH's biomedical research programs. This is an unset-aside, commercial...
This is a firm fixed-price service contract awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Quanterix Corporation, a for-profit manufacturer of digital biomarker analysis technology. The contract, valued at $15,000.00, is for Quanterix to provide Simoa detection platform instruments, assay kits, reagents, and maintenance services to support NIH research on diseases such as Alzheimer's, post-traumatic stress disorder, and infectious...
This contract was awarded by the Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Institute on Drug Abuse to Quanterix Corporation, a life sciences company that provides ultra-sensitive digital biomarker detection technology. The $149,000 firm-fixed-price purchase order is to analyze 9 human biomarkers from 1,122 samples. This work supports the NIH's research examining the relationship between inflammation and aging. Quanterix has been awarded over $30...
This is a firm-fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Quanterix Corporation, a life sciences company specializing in ultra-sensitive digital biomarker detection technology. The contract, valued at $99,653.76, is for the supply of assay kits. This award is not designated as a set-aside contract. Quanterix is the prime contractor and has not reported any major subcontractors for this award. The company has a history of federal...
The contract award to Quanterix Corporation, a life sciences company specializing in digital biomarker detection technology, was issued by the National Institute on Drug Abuse, part of the National Institutes of Health. The $151,775.25 firm-fixed-price purchase order is for the provision of advanced instruments, assay kits, and research services to support biomedical research and diagnostic development. This contract is not designated as a set-aside. Quanterix has also been awarded an indefinite...
This firm-fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services, to Quanterix Corporation for a Quanterix SR-X Ultra-Sensitive Biomarker Detection System and related equipment and services. The total ceiling value of the contract is $89,500.00. This award is not associated with a set-aside program. Quanterix Corporation is a life sciences company that specializes in ultra-sensitive digital biomarker detection technology, and has provided products and services to various federal agencies, including NIAID, to support biomedical research and diagnostic development. The contract is for equipment and training to support NIAID's biomarker analysis needs, specifically the measurement of proteins at low concentrations, replacing an older Quanterix HD-1 Analyzer system that is no longer supported.